There were 826 press releases posted in the last 24 hours and 442,283 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zealand Pharma's first Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia successfully meets its primary objective

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image